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Abstract  
Diabetes Mellitus is a very common, costly and manageable chronic disease, posing a major 
public health concern in the United States. The Center for Disease Control (CDC), 2015, 
estimate that one million Americans are living with diabetes; with Type 1 diabetes accounting for 
about 5% of all cases diagnosed with diabetes. The American Diabetes Association (ADA), 
defines type 1 diabetes as “beta-cell destruction, usually leading to absolute destruction of beta 
cells of pancreas usually leading to absolute insulin deficiency.”  Patients with DM especially 
type 1 diabetic patients, need thorough evaluations before, during and after surgery due to the 
high complexity and risk of perioperative infections, cardiovascular morbidity and mortality after 
surgery. This case report and literature review will highlight the management of the type 1 
diabetic patient during the perioperative and postoperative phase of surgery.  Proper 
perioperative management of the surgical adult with type 1 diabetes is aimed at decreasing 
adverse cardiovascular events, morbidity and mortality, reducing prolonged hospitalizations and 
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  Background   
With about one million type 1 diabetic patients in the United States today, the ADA, 
2016, estimates that about 25%-50% of diabetic patients will need surgery at some point in their 
lives. Compared to nondiabetic persons, diabetic patients account for a greater majority of the 
surgical population annually, with increased mortality rates up to 5 times more than in 
nondiabetic patients (ADA, 2016). About 21% of adults 60 years of age and older have diabetes, 
with this number expected to double by 2025 (Vann, 2009). The ADA,2016, estimated the total 
cost of diagnosed diabetes in the United States in 2012 at $245 billion, with direct medical cost 
at $176 billion resulting in $69 billion of reduced productivity. 
 My case report presents a 67 year old Caucasian male with type 1 diabetes who is being 
evaluated for a right total knee replacement and has an insulin pump. Thorough assessment, 
planning and coordination with the patient’s endocrinologist and diabetic team during the 
perioperative period is very important. This is because type 1 diabetic patients are insulin 
dependent requiring continuous basal supply of insulin which can be via subcutaneous insulin 
injections or via insulin pump as in the case of my patient. This patient population needs optimal 
perioperative glycemic management by experienced healthcare professionals (Patridge, Perkins, 
Mathieu, Nicholls, & Adeniji, 2016). This leads to decreased adverse outcomes such as 
hypoglycemia associated with intensive insulin therapy and diabetic keto acidosis commonly 
seen with type 1 diabetic patients (Chiang, Kirkman, Laffel, Peters, & Type 1 Diabetes 
Sourcebook Authors, 2014).  These patients are also at risk for increased medical complications, 
higher readmission rates or to be readmitted within 30 days after joint replacements 
(Lovecchioer, Beal, Kwasny, & Manning, 2014).     
MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY  5 
Glycemic control during the perioperative period for patients with type 1 diabetes can be 
very challenging for clinicians leading to lengthened hospital stays, increased used of healthcare 
resources, increased risk for perioperative and post-operative infections and greater perioperative 
mortality compared to non-diabetic patients (Williams, 2007). Management challenges for type 1 
diabetes mellitus during the perioperative period include lack of standardized diabetic care 
guidelines within institutions, associated hypoglycemia or hyperglycemia, co-morbidities, 
complexities with polypharmacy and insulin prescription errors and limited knowledge of 
diabetic management among staff providing care to this patient population (Barker et al., 2015). 
Adequate management of type 1 diabetic patients is therefore critical during the perioperative 
period to prevent adverse patient outcomes, reduce mortality and save on scarce healthcare 
resources.  
 Diabetic surgical patients usually fall into a higher risk category compared to non-
diabetics, therefore optimizing perioperative management will require thorough evaluations to 
minimize renal, cardiovascular and neurologic complications (Khan, Ghali & Cagliero, 2016). It 
is therefore imperative for the health care team including surgeons, anesthesiologist and other 
specialists who perform surgical procedures to have an in-depth knowledge of type 1 diabetes 
and how it affects the overall care delivery process.  Close glycemic monitoring perioperatively 
will reduce microvascular and macrovascular complications in the type 1 diabetic patient. The 
dilemma still remains as to what method is optimal in the perioperative management of adults 
with type 1 diabetes to prevent adverse surgical outcomes. This case report will examine the 
perioperative management of type 1 diabetics, some challenges clinicians encounter and how to 
optimize care for this patient population. 
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 Case Report 
Mr. JX is a pleasant 67 year old adult Caucasian male with type 1 diabetes mellitus who 
presents to the clinic for a pre-operative evaluation for a right total knee arthroplasty/ 
replacement. Surgery has been scheduled to take place at the orthopedic hospital three weeks 
from this pre-operative visit. About two months ago Mr. J.X. had a left total knee 
arthroplasty/replacement and stated surgery was successful, but for issues with his blood sugars 
“bottoming out during surgery,” needing urgent glycemic control and intervention. Patient has a 
history of arthritis in both knees that has caused him significant discomfort, thus the need for 
total knee replacements bilaterally. Patient says his right knee gets weak, causing constant pain, 
aggravated with ambulation, and relieved by rest, using a cane for support or nonsteroidal ant-
inflammatory drugs (NSAIDs) like ibuprofen. He had a fall 6 months ago, which was caused by 
his right knee gave out. Patient denied any bruising or bleeding after fall.  
Other pertinent past medical history include; hypertension, sleep apnea, hyperlipidemia, 
diagnosed with type 1 diabetes in 1973 at age 6 years, carotid artery disease with about 60% 
blockage bilaterally, left knee injury in 1970 during a football game stating “left knee was 
clipped.” Patient denies any other heart diseases or respiratory problems. Patient denies any 
allergies. He denies having any problems with anesthesia or family complications from 
anesthesia.  Significant surgeries include bilateral knee arthroscopes, left knee 
replacement/arthroplasty, two hernia repairs and an appendectomy. Patient does not use any 
home oxygen. Denies any recent acute or chronic infections. Patient denies bruising or bleeding 
easily. He has no family history of bleeding or clotting disorders. Patient is independent at home, 
has no trouble climbing stairs or a hill. He denies any shortness of breath or dizziness with 
ambulation and walks his dog for about 2 miles daily. He also denies any recent chest pain, 
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arrhythmias or congestive heart failure. Denies any history of Chronic Obstructive Pulmonary 
disease or asthma. 
Patient’s family/social history includes cardiovascular disease on father’s side. His father 
died of a heart attack at age 69 years and his brother had a stroke. He also lost a brother to 
esophageal cancer. Patient states he smokes a pack of cigarettes a day and is trying to quit. 
Patient denies using any illicit drugs. Patient states he eats a balanced diet consisting of “meats, 
potatoes and lots of fruits and vegetables.” For medications, patient is currently taking losartan 
10mg, simvastatin 80mg, aspirin 81mg and multivitamins. He also has an insulin pump and 
checks his blood sugars four times a day with numbers averaging 140mg/dl. Patient’s average 
blood pressure at home are in the 130’s/80’s range. Patient had a normal stress test done a year 
ago. Also says chest X-Ray was done in the past with no significant findings. 
Patient’s physical exam was negative for wheezes, crackles, jugular vein distention, 
carotid bruit or lower extremity edema. Significant findings during were a high blood pressure 
reading of 158/94. Pre-operative labs and tests ordered during this visit include a complete blood 
count with results of red blood cells slightly decreased at 3.0  10^6/uL and hematocrit at 34.5% 
probably due to some blood loss from previous left total knee replacement done two months ago. 
Patient’s comprehensive metabolic panel came back normal. EKG indicated a normal sinus 
rhythm. With above elevated blood pressure readings, history of hypertension, and patient 
scheduled for surgery in three weeks, elevated blood pressures will have to be addressed before 
surgery. 
 The most significant plan for this patient included normalizing his blood pressure by  
adding a beta blocker, such as metoprolol 25 mg with recommendations to keeping blood 
pressure below 140/80 mmHg and monitor closely at home, reporting any abnormal readings 
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before surgery. Patient will continue to monitor blood sugars at home and keep a log to be 
reviewed before surgery. Lifestyle modifications such as quitting smoking especially before 
surgery was discussed including benefit to overall health and patient outcomes given other 
associated risk factors for stroke and coronary  artery disease. He was encouraged to continue 
heart healthy diet and daily exercises. Patient also informed to stop aspirin a week before surgery 
to reduce risk of bleeding. Some expectations during the perioperative period such as hospital 
length of stay, glycemic control and discharge were discussed with patient. After reviewing, 
patient’s history, medications, labs, imaging, physical exam and plan, patient was cleared for 
surgery. 
Literature Review   
According to the American Diabetes Association (2016), type 1 diabetes represents 5% of 
all diagnosed diabetes cases, with diabetic patients accounting for a larger proportion of people 
needing surgery, and have a higher perioperative risk for complications and longer hospital stays 
compared to the nondiabetic population.  About 21% of adults 60 years of age and older are 
diagnosed with diabetes and is projected to double by 2025. The complexity of type 1 diabetic 
patients during surgery can pose a challenge to clinicians needing careful assessment and 
planning (Khan et al., 2016). It is therefore important to conduct thorough evaluations and 
careful management during the perioperative period to prevent adverse outcomes post-
operatively for type 1 diabetic patients.      
 A literature review was conducted to examine the perioperative, and post-operative 
management of adults with type 1 diabetes outlining some challenges faced by clinicians. An in 
depth search was conducted to review the most current literature using the University of North 
Dakota’s Harley E. French Library of Health Sciences. PubMed was one of the online databases 
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used to conduct a systematic search of literature with key word search using MeSH terms of type 
1 diabetes AND intraoperatively within the last 5 years yielding 3 articles with two relevant 
articles for my case report. Using  PubMed,  other MeSH terms like Perioperative AND 
management AND diabetes mellitus, type 1, within the past 5 years yielded 17 articles with 6 
articles being of relevance to my topic discussion. These 7 articles in their reference sections had 
about 6 to 8 other relevant articles used for my literature review. The ADA grading system used 
in the literature review range from A, B, C or E. A represents clear recommendations from well 
conducted, generalizable randomized controlled trials that are adequately powered. B grade 
means supportive evidence from well conducted cohort studies, C grade provides supportive 
evidence from poorly or uncontrolled studies and E grade is expert consensus or clinical 
experience (ADA, 2016).  
The Importance of Managing Diabetes in the Surgical Setting  
The stress of surgery and anesthesia has been known to activate the neuroendocrine 
response, leading to a secretion of counter regulatory hormones such as cortisol and epinephrine, 
impacting the action of insulin and predisposing the patient to ketoacidosis and hyperglycemia 
(Rizvi, Chillag & Chillag, 2010). Hyperglycemia is also a risk factor for cerebral ischemia, 
impaired wound healing, increased hospital stay.  
 According to Sudhakaran & Surani, (2015), recent evidence has shown that careful 
glycemic control for diabetic patients undergoing major surgery including cardiac and orthopedic 
procedures may decrease adverse surgical complications and lead to better patient outcomes.  
Glycemic control in the perioperative setting especially for type 1 diabetics is done to recognize 
hypoglycemia which if missed can result in a number of neurologic complications including 
seizures, unconsciousness, somnolence, irreversible neurological insult and death. Sometimes 
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recognizing the adverse neurological effects of hypoglycemia can be difficult post operatively 
especially when the patient has been under anesthesia resulting in unrecognized hypoglycemia 
for a critical length of time before proper glycemic correction is ensured (Sudhakaran & Surani, 
2015). In order to optimize glycemic control and prevent adverse surgical outcomes during the 
perioperative period, clinicians need to be vigilant and properly identify diabetes, glucose 
intolerance, insulin resistance and associated diabetic diseases and comorbidities.  
Preoperative Evaluation   
Preoperative evaluation in the primary care setting for diabetes mellitus especially in type 
1 diabetics is important in identifying risk factors, type of anesthesia to be used, improving 
efficiency intraoperatively, reduce unnecessary testing and consultations, improving patient 
education and satisfaction and decreasing perioperative complications. 
 During preoperative evaluations preoperative testing and laboratory evaluation should 
include at least an electrocardiogram, a basic metabolic panel to assess renal function, 
hemoglobin, electrolytes and hemoglobin A1c levels. Also knowing the type of diabetes and its 
treatment must be considered as type 1 diabetics require continuous insulin therapy to prevent 
diabetic ketoacidosis and hypoglycemia. Information of patient’s hemoglobinA1c may be 
beneficial in not only classifying perioperative risk but to also determine care during the 
postoperative phase. Asymptomatic diabetic patients who have cardiac risk factors such as 
hypertension, tobacco use, or family history of cardiovascular disease should undergo cardiac 
image/stress testing to rule out coronary artery disease before general anesthesia as an EKG 
alone might not be sufficient in diagnosing silent coronary artery disease. The primary care 
provider also needs to be familiar with the patient’s medications including mechanism of action 
and those that are contraindicated during the perioperative period (Meneghini, 2009). 
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  The diabetic patient needing surgery should also be closely assessed preoperatively for 
signs and symptoms of cerebrovascular, coronary artery disease and peripheral vascular disease. 
Any comorbid health conditions must be identified and carefully managed perioperatively.  Beta-
blockers should be considered in diabetic patients with coronary artery disease to decrease risk of 
perioperative ischemia. Preoperative goals for the type 1 diabetic surgical patient will be to 
assess the patient’s overall health status, uncover conditions that can pose a problem during and 
after surgery, determine the perioperative risk, optimize the patient’s medical condition to 
decrease adverse surgical outcomes, formulate a concise perioperative plan of care and educating 
the patient about what to expect during the perioperative and postoperative and discharge period 
in order to reduce patient anxiety (Zambouri, 2007). 
 According to Koo, Hyder, Wanderer, Eikermann & Ramachandran (2015), the 
perioperative risk assessment is done using the American Society of Anesthesiologists’ 
Classification of Physical Status. The ASA grading system which ranges from ASA class 1 to 
class 6 according to severity of the patient’s disease state and E for emergency surgery, remains 
one of the few prospective descriptions of the patient’s general health which correlates with the 
risk of anesthesia and surgery. Koo et al., conducted a meta-analysis combining 77 studies and 
165,705 patients to predict the accuracy of postoperative mortality using the ASA physical status 
classification and found that even though it was a better predictor of postoperative mortality, it 
was more effective in settings with lower than higher death rates (Koo et al., 2015). My patient 
will be considered to be an ASA class II as patient underneath this category are those with mild 
systemic disease.     
A study by Hollenberg and colleagues found that diabetes is one of the five independent 
risk factors for postoperative myocardial ischemia and insulin-independent diabetes is one of the 
MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY  12 
five clinical risk factors on the Revised Cardiac Risk Index and this index looks for major 
cardiac complications, including cardiac arrest, myocardial infarction, heart failure and heart 
block. The preoperative assessment of cardiac risk is done according to the American College of 
Cardiology/American Heart Association guidelines (Miller & Richman, 2016).   
A retrospective observational study was conducted by Kallio et al. (2015) to test the 
hypothesis that anesthesia preoperative clinic referral for elevated glycosylated hemoglobin 
reduces complication rates after total joint arthroplasty. The total number of patients in this study 
was 203 with and without DM selected from 1,237 patients undergoing TJA from 2006 to 2012. 
Patients who were evaluated in the anesthesia preoperative clinic had surgery in 2006 to 2008 
irrespective of HbA1c. Patients evaluated in two year intervals were referred to primary care for 
HbA1c greater than 10% and 8% respectively to improve glycemic control before surgery. 
Complications and mortality were quantified postoperatively at three, six and twelve months. 
Length of stay and prolonged stays (greater than 5 days) were recorded.  The results of this study 
showed that patients undergoing TJA with uncontrolled HbA1c and those with HbA1c less than 
10% but not those with HbA1c less than 8% had a higher incidence of coronary artery disease 
and hypercholesterolemia and increased complication rates than patients without DM. Also 
complication rates significantly decreased with tighter HbA1c control. The study saw an increase 
in prolonged hospital stay for DM patients with uncontrolled HbA1c greater than 10% versus 
those without DM. From this study we see the importance in referring DM patients to primary 
care providers for preoperative evaluations as it reduced complications rates and the incidence of 
prolonged hospitalizations during the first year after surgery in diabetics undergoing TJA. 
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Perioperative Glycemic Management 
There is an increased mortality for diabetics undergoing surgery, especially Type 1 
diabetics who are particularly at risk for postoperative complications. The successful 
management of the type 1 diabetic patient during surgery therefore requires safe and simple 
protocols that can be understood by all staff to decrease surgical errors and optimize glycemic 
control. 
There have been several management strategies proposed to maintain target range 
glucose perioperatively, but there is no consensus as to what strategy remains optimal. According 
to Khan et al. (2015), most protocols for insulin administration have been formulated by expert 
opinion and clinical experience. Decisions as to which strategy to use will depend on the hospital 
setting, individual patient, resources and clinician judgement. In a meta-analysis of 12 
randomized trials, with 1,403 diabetic patients, intensive (<120 or <150mg/dL) versus 
conventional (variable) glycemic control during the perioperative period, intensive glycemic 
control perioperatively was not associated with any reduction in infectious complications, 
cardiovascular events or mortality but had an increased risk for hypoglycemia. In this study the 
mean difference for achieving blood glucose levels between the intensive and conventional 
group ranged from -13 to 91 mg/dL (0.72 to 5.0 mmol/L) (Khan.,Ghali.,Cagliero,2015).  
Buchleitner et al., in a systemic review identified 12 trials randomizing 694 diabetic 
participants to the intensive control group and 709 diabetic participants to the conventional 
glycemic control group, with mean age at 64 years. Duration of intervention ranged from the 
duration of the surgical procedure up to 90 days. Despite achieving low blood glucose 
concentrations during the perioperative period, intensive glucose control did not significantly 
reduce the risk of important postoperative outcomes such as infections, cardiovascular 
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complications, renal failure or increased hospital stay. However intensive glycemic control was 
associated with increased hypoglycemia episodes in diabetic patients in the intensive glycemic 
group. The authors came to the conclusion that intensive glycemic control protocols with blood 
glucose near normal targets for patients with diabetes mellitus undergoing surgical procedures 
are currently not supported by an adequate scientific basis. For the future studies, these authors 
recommend that insulin protocols, patient and healthcare outcomes should be defined in a 
thorough and uniform way (Buchleitner et al., 2012).  
 Another study by Van den Berghe and colleagues on intensive insulin therapy in the 
surgical intensive care unit showed that patients demonstrated a major reduction in morbidity and 
mortality when glucose levels were controlled strictly, ranging from 80 to 110mg/dL, averaging 
103 mg/dL, compared with conventional control of 180 to 200 mg/dL. The study also 
demonstrated benefits of intensive glycemic control which was seen to reduce outcomes such as 
sepsis, need for dialysis, need for blood transfusion and the development of polyneuropathy. 
Intensive insulin therapy also led to cost saving compared to conventional insulin therapy 
(Meneghini, 2009).  
Finfer et al. (2009), designed a Normoglycemia in Intensive Care Evaluation-Survival 
Using Glucose Algorithm Regulation (NICE-SUGAR) trial to test the hypothesis that intensive 
glucose control reduced mortality at 90 days. A randomized controlled trial included adult 
medical and surgical patients admitted to the ICU of 42 hospitals were assigned to an intensive 
control target (81 to108 mg/dL) and a conventional control target of 180 mg/dL or less. Blood 
glucose control was obtained with use of an intravenous infusion of insulin and saline. Blood 
glucose measurements were obtained by arterial blood gas analyzers, laboratory analyzers or by 
point-of-care. Use of capillary sample were discouraged. Results of this study showed that 206 
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out of 3,016 patients in the intensive control group experienced severe hypoglycemia (blood 
glucose <40mg/dL) compared to 15 of the 3,014 patients in the conventional control group. 
There was also no significant difference between the two treatment groups in regards to the 
average number of days in the ICU, hospital or renal-replacement therapy. This study therefore 
concludes that there is an increase in mortality among ICU adult patients with intensive glucose 
control of 81 to 108 mg/dL compared to lower mortality when blood glucose targets are 
180mg/dL or less (Finfer et al., 2009).  
However, the  Society for Ambulatory Anesthesia states that even though hyperglycemia 
may be linked to increased morbidity and mortality in diabetic patients undergoing major 
surgery, several randomized controlled trials evaluating tight perioperative glycemic control (80 
and 110mg/dL) have reported inconsistent results, with some studies reporting harm to patients. 
Tight control warrants frequent blood glucose monitoring making glycemic management more 
complex. Regardless of the above studies, major professional organizations such as the Centers 
for Medicare and Medicaid Services, recommend tight glycemic perioperative control as a 
national quality improvement initiative (Joshi et al., 2010). 
 Despite differences with above findings most of the author’s main goal for the 
perioperative period is to avoid hypo or hyperglycemia and maintain adequate blood glucose 
control to decrease morbidity and mortality in the diabetic patient especially the adult type 1 
diabetic patient.    
Sudhakaran and Surani, (2015), in light of recent research have proposed perioperative 
management guidelines for the diabetic patient. Type 1 diabetic patient need to continue a basal 
insulin replacement preoperatively (0.2 to 0.3 U/kg/day) of a long acting insulin.  For 
intraoperative glycemic management, even though there is no consensus for target range, current 
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literature suggest keeping blood glucose levels between 150 and 200 mg/dL during surgery. This 
is due to studies that have found increased morbidity and mortality with intraoperative 
hyperglycemia (glucose above 200mg/dL) as well as relative normoglycemia (glucose less than 
140mg/dL) also found to be associated with significant mortality and morbidity.  
Khan et al, 2015, suggest that for short procedures lasting less than 2 hours, type 1 
diabetic patients who use insulin can continue subcutaneous insulin perioperatively rather than 
an insulin infusion. For morning procedures patients should also delay taking their morning 
insulin until after surgery and before they eat. Patients who are on continuous insulin pumps may 
continue their basal insulin without any changes to their regular regiment given that their basal 
insulin dose can be calculated correctly, with catheter and pump remaining safely in place during 
surgery. Preoperative hypoglycemia can be avoided in patients with a known history of 
hypoglycemia as an outpatient by reducing their basal rate by 10 to 20%.  
 Khan et al., 2015 recommend that for long complex procedures, IV insulin is 
usually required. Studies have compared the use of subcutaneous insulin versus IV infusion and 
found a significant increase in the variability of the glucose concentration when using the 
subcutaneous route, attributed to different rates of insulin absorption when hypothermia, 
vasoconstriction or hypoperfusion occurs. Many studies have shown the safety of IV insulin 
infusions in highly monitored settings. Also insulin infusions can be more readily titrated due to 
its short half-life of IV insulin (5 to 10 minutes), enabling more precise glucose control.  With IV 
insulin infusions, blood glucose should be monitored every hour and more frequently if blood 
glucose levels are <100mg/dL or it rates fall rapidly which can be an indication for 
hypoglycemia. Preferred method for intraoperative glucose testing is by laboratory or point of 
care testing, not finger stick glucose levels as they are less reliable. For sedated anesthetized 
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patients, with a blood glucose less than 70 mg/dL IV dextrose 25mg is administered and repeat 
glucose measurements in 5 to 10 minutes. In the awake patient that can swallow, symptomatic 
hypoglycemia is treated with at least 15 g of carbohydrate. (Khan et al. 2015) 
     The American Association of Clinical Endocrinologist and the ADA, 2009, 
recommend that IV infusion therapy be administered by means of validated protocols or 
computerized protocols enabling adjustments in insulin infusion rates based on glycemic 
fluctuations and insulin dose. They emphasize on the fact that systems put in place to ease the 
appropriate use of scheduled insulin therapy, with institutional support for inpatient personnel 
who are knowledgeable in glycemic management are important for achieving safe and 
reasonable levels of glycemic control in hospitalized diabetic patients. A Portland Diabetic 
project, a 17 year prospective nonrandomized study of 4,864 patients with diabetes who 
underwent open-heart surgery, the implementation of a continuous IV insulin therapy to achieve 
predetermined target BG levels reduced the incidence of deep sternal wound infections by 66% 
resulting in a total net savings to the hospital of about 4,638 USD per patient (Furnary, Wu & 
Bookin, 2004; Moghissi et al., 2009).   
Most recent recommendations form the American Diabetes Association (2016) about 
diabetes care in hospitals, recommend initiating insulin therapy for persistent hyperglycemia 
with blood sugars levels above 180mg/dL for critically ill patients and with target range of 140-
180 mg/dL with a grade recommendation of grade A. Tighter glycemic control may be needed 
for specific critically ill patients such as 110-140mg/dL as long as hypoglycemia can be 
prevented. Insulin infusion should be administered using validated or written or computerized 
protocols that allow for predefined adjustments of insulin (E grade). Hypoglycemia management 
protocols should be developed by each hospital with individualized plans to prevent 
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hypoglycemia for each patient (Grade E). The ADA, in their recent recommendations have also 
agreed that tight glycemic control from research studies has led to increased mortality versus 
moderately controlled cohorts and have reflected these glycemic changes mentioned above for 
diabetic hospitalized patients. Tight glycemic control is therefore reserved for patients with a 
successful history in an outpatient setting who are stable clinically and can be maintained with 
glucose levels less than 140mg/dL (ADA, 2016)  
Patridge et al. (2016), place clear emphasis the fact that hospitals and health care 
organizations have to come up with clear, concise and standardized national and international 
guidelines for inpatient management of type 1 diabetic patients with insulin pumps during 
surgery. As of yet most of  recommendations are based on case reports with little evidence 
available to drive these recommendations as they are still non-standardized and based on local 
guidelines. With very limited research, on the use of insulin pump therapy during the 
perioperative period, the Joint British Diabetes Society (JBDS) have offered a set of guidelines 
and recommendations for the management of type 1 diabetes perioperatively. 
 The JBDS recommend that type 1 diabetic patients on insulin pumps undergoing surgery 
need to be reassured depending on the type of surgery that they will be receiving similar insulin 
therapy either through IV insulin or the form of multiple daily injections. Elective surgery for 
type 1 diabetic patients with adequate planning with the diabetic is recommended with HbA1c 
less than 8.5% using models like the Bournemouth diabetes surgical pre-assessment service to 
prevent micro and macrovascular complications. The JBDS also recommend that patients 
continue to use their insulin pumps and regiments for elective procedures while following 
instructions regarding fasting by the anesthetic team. Patridge et al, 2016 reviewed other 
recommendations from Australia recommending patients use 80% basal insulin rates upon 
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initiation of surgery used on a temporary basis and resumed to normal upon consciousness and 
when patient is able to manage their blood sugars. These conflict with recommendations from the 
United Kingdom for surgery as they recommend patients to continue their insulin at a 100% 
basal rate due to basal rate assessments done during the pre-operative assessment.  
 The JBDS also recommend the discontinuation of insulin pumps during major surgery 
replacing it with IV insulin which is started at least halve an hour before discontinuing patient’s 
insulin pump. They also strongly advise against using continuous glucose monitor devices 
attached to insulin pumps as a means of checking blood glucose during surgery due to 
discrepancies (Partridge et al., 2016). 
Similar to other recommendations mentioned in the literature review it is strongly 
recommended that blood glucose be checked every hour preoperatively, perioperatively and 
postoperatively. As with other studies, Patridge et al, also assert that adequate glycemic targets 
during major and minor surgeries have been controversial as studies conducted by Van den Bergh 
proposing for tighter and conservative glycemic control (80-110 mg/dL), improving mortality 
compared with a more conservative approach have not been supported by the NICE-SUGAR 
study that opted for a more conservative blood sugar target, between 6mmol/l (108mg/dL) to 
10mmol/l (180mg/dL).   
Despite recommendations, studies, and epidemiologic studies, associating poor clinical 
outcomes to hypoglycemia, data show that insulin-induced hypoglycemia as causing direct harm 
to hospitalized patients is scarce. The strategies discussed above, even though effective have not 
been proven to optimally reduce outcomes of morbidity or mortality and the length of hospital 
stays. Many of the management strategies above require further investigation  
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Postoperative Glycemic Management  
Due to effects from anesthesia, and other postoperative complications, glycemic control 
during the postoperative phase for type 1 diabetic patients can pose a challenge to clinicians. To 
minimize postoperative complications diligent blood glucose management is very important. 
During the postoperative phase, patients are usually transitioned to subcutaneous insulin 
when they begin eating or are transferred in to a lower-intensity of care after IV insulin infusions. 
Subcutaneous insulin must be administered 1-4 h before the discontinuation of IV insulin therapy 
to prevent hyperglycemia is the preferred methods of maintaining blood glucose control in the 
non-critical, non-ICU setting .With these recommendations, these authors note that “an effective 
transition regime has not been substantiated” (Moghissi et al.,2009).  Recommendations by Khan 
et al, 2015, indicate continuation of insulin infusion postoperatively for patients who do not 
resume eating postoperatively and once food is tolerated they can be switched to subcutaneous 
insulin or insulin pump based on their outpatient regime to complement what is being eaten. It is 
important that basal insulin levels remain stable after intraoperative IV insulin discontinuation 
for type 1 diabetic patients to prevent diabetic ketoacidosis. Meanwhile there is no clear 
consensus on postoperative management other sources recommend the transition from IV to 
subcutaneous insulin 12 to 24 hours prior to stopping the insulin drip to reduce the change of 
diabetic ketoacidosis in type 1 diabetic patients (Sudhakaran & Surani,2015).   The Society of 
Thoracic Surgeons as well as the AACE/ADA consensus recommend that postoperative glycemic 
ranges be between 140 to 180mg/dL. (Sudhakaran and Surani, 2015). The authors above from 
recent literature and recommendations all agree on adequate and safe glycemic control in the 
postoperative period while maintaining stable basal insulin levels for type 1 diabetics to prevent 
adverse outcomes such as diabetic ketoacidosis. All articles reviewed did not show a clear 
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consensus or any main optimal glycemic management during the postoperative period for type 1 
diabetics. 
Patridge et al. (2016), in regards to postoperative recommendations from the JBDS allow 
for hourly blood sugar checks until patients are fully conscious to make decisions regarding their 
insulin pumps. Also aware of post hyperglycemia for the conscious patient an hour or two hours 
after surgery the patient’s insulin pump built in bolus calculator should be able to adjust the 
correct insulin dose needed to bring down the patient’s blood glucose.  Patients are also strongly 
encouraged to frequently monitor their blood sugars 1 to 2 days after surgery to re-establish their 
baseline status. These authors suggest that there have been studies showing benefits of lower 
fasting glucose on the first day postoperatively and more stable blood glucose in patients 
remaining on insulin pump therapy during elective surgery than those on non- insulin pump 
therapy even though trial designs and data in other studies remain  ambiguous  and in conclusive.  
 Transitioning the patient to the outpatient setting takes the responsibility from the 
hospital personnel to self-management by the type 1 diabetic patient.  During the discharge 
process, successful transition requires a team approach by the endocrinologists, nurses, 
dieticians, diabetic educators’ case managers social workers and other involved clinicians. Before 
discharging patient to the home setting, certain areas such as understanding diabetes diagnosis, 
self- monitoring of BG at home, recognition, treatment and prevention of hyper or 
hypoglycemia, diet, how to administer BG lowering medications or ongoing management if on 
insulin pump will be very important to review with the patient (Moghissi et al,2009). This is 
done to identify areas of knowledge deficits in the type 1 diabetic patient so they can be better 
educated prior to discharge, leading to better self-management at home.  
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The ADA (2016) recommend follow up visit within one month post discharge for all 
diabetic patients who experienced hyperglycemia in the hospital with the patients primary care 
provider or endocrinologist. There should also be hospital guidelines to resume patient’s 
medication regiment one to two days before discharge. 
Learning Points 
 In the primary care setting, preoperative evaluations for the type 1 diabetic adult patient 
needing surgery are vital evaluations as they identify important risk factors before 
surgery that that if missed can lead to adverse surgical outcomes. During this stage care 
coordination, medication reconciliation and management of presenting health problems 
are addressed which has led to a reduction perioperative and postoperative morbidity and 
mortality.  
 Overtreatment or under treatment of hypoglycemia still remains a major safety concern 
during the perioperative and post-operative management  of Type 1 diabetic patients and 
can be very challenging for clinicians. Proper identification of high risk patients is vital in 
the overall perioperative and postoperative management phase to prevent adverse surgical 
outcomes. 
 Clear guidelines and protocols need to be developed by hospitals for the inpatient 
management of type 1 diabetic patients on insulin pumps with in service and education 
for all healthcare providers who are most likely to encounter these group of patients, in 
close collaboration with the diabetes team such as the endocrinologist and insulin pump 
nurse specialist.  
 Intensive glycemic control programs for inpatient glycemic control for type 1 diabetic 
patients is backed by current evidence based research (even though studies reveal 
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conflicting data). Tight glycemic control appears to result in fewer in patient 
complications, reduced ICU and hospital stays, significant decreased morbidity and 
mortality and decreased cost.   
 Proper discharge planning, thorough patient education and clear communication among 
the interdisciplinary team members and outpatient providers is critical in accomplishing a 
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2012). Perioperative Glycaemic Control for Diabetic Patients Undergoing Surgery. The 
Cochrane Database of Systematic Reviews, 9. 
Bolognesi, M. P., Marchant, M. H. J., Viens, N. A., Cook, C., Pietrobon, R., & Vail, T. P. 
(January 01, 2008). The Impact of Diabetes on Perioperative Patient Outcomes after Total 
Hip and Total Knee Arthroplasty in the United States. The Journal of Arthroplasty, 23, 6, 
92-8. 
Center for Disease Control (2015). Basics about Diabetes. 
.  
 
MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY  25 
Chiang, J. L., Kirkman, M. S., Laffel, L. M., Peters, A. L., & Type 1 Diabetes Sourcebook 
Authors. (January 01, 2014). Type 1 Diabetes through the Life Span: A Position 
Statement of the American Diabetes Association. Diabetes Care, 37, 7, 2034-54. 
Furnary, A. P., Wu, Y., & Bookin, S. O. (January 01, 2004). Effect of Hyperglycemia and 
Continuous Intravenous Insulin Infusions on Outcomes of Cardiac Surgical Procedures: 
The Portland Diabetic Project. Endocrine Practice : Official Journal of the American 
College of Endocrinology and the American Association of Clinical Endocrinologists, 10. 
Finfer, S., Chittock, D. R., Su, S. Y., Blair, D., Foster, D., Dhingra, V., Bellomo, R., NICE-
SUGAR Study Investigators. (January 01, 2009). Intensive versus Conventional Glucose 
Control in Critically Ill Patients. The New England Journal of Medicine, 360, 13, 1283-
97. 
Joshi, G. P., Chung, F., Vann, M. A., Ahmad, S., Gan, T. J., Goulson, D. T., Merrill, D. G., 
Society for Ambulatory Anesthesia. (January 01, 2010). Society for Ambulatory 
Anesthesia Consensus Statement on Perioperative Blood Glucose Management in 
Diabetic Patients Undergoing Ambulatory Surgery. Anesthesia and Analgesia, 111, 6, 
1378-87. 
Khan,A.N., Ghali,A,W., Cagliero.E.(2015). Perioperative Management of Blood Glucose in 





MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY  26 
Kallio, P. J., Nolan, J., Olsen, A. C., Breakwell, S., Topp, R., & Pagel, P. S. (January 01, 2015). 
Anesthesia Preoperative Clinic Referral for Elevated Hba1c Reduces Complication Rate 
in Diabetic Patients Undergoing Total Joint Arthroplasty.Anesthesiology and Pain 
Medicine, 5, 3.) 
Koo, C. Y., Hyder, J. A., Wanderer, J. P., Eikermann, M., & Ramachandran, S. K. (January 01, 
2015). A Meta-Analysis of the Predictive Accuracy of Postoperative Mortality Using the 
American Society of Anesthesiologists' Physical Status Classification System. World 
Journal of Surgery, 39, 1, 88-103. 
Lovecchio, F., Beal, M., Kwasny, M., & Manning, D. (2014). Do Patients with Insulin-
Dependent and Noninsulin-dependent Diabetes Have Different Risks for Complications 
after Arthroplasty? Clinical Orthopaedics and Related Research, 472(11), 3570–3575. 
http://doi.org.ezproxy.undmedlibrary.org/10.1007/s11999-014-3891-4 
Meneghini, L. F. (January 01, 2009). Perioperative Management of Diabetes: Translating 
Evidence into Practice. Cleveland Clinic Journal of Medicine, 76, 53-9. 
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., 
Inzucchi, S. E., American Diabetes Association. (January 01, 2009). American 
Association of Clinical Endocrinologists and American Diabetes Association Consensus 
Statement on Inpatient Glycemic Control. Diabetes Care, 32, 6, 1119-31. 
Partridge, H., Perkins, B., Mathieu, S., Nicholls, A., & Adeniji, K. (January 01, 2016). Clinical 
Recommendations in the Management of the Patient with Type 1 Diabetes on Insulin 
Pump Therapy in the Perioperative Period: A Primer for the Anaesthetist. British Journal 
of Anaesthesia, 116, 1, 18-26. 
 
MANAGEMENT OF TYPE 1 DIABETES PERIOPERATIVELY  27 
 
 
Rizvi, A. A., Chillag, S. A., & Chillag, K. J. (January 01, 2010). Perioperative Management of 
Diabetes and Hyperglycemia in Patients Undergoing Orthopaedic Surgery. The Journal of 
the American Academy of Orthopaedic Surgeons, 18, 7, 426-35. 
Sudhakaran, S., & Surani, S. R. (January 01, 2015). Guidelines for Perioperative Management of 
the Diabetic Patient. Surgery Research and Practice, 2015, 5, 1-8. 
Vann, M. A. (January 01, 2009). Perioperative Management of Ambulatory Surgical Patients 
with Diabetes Mellitus. Current Opinion in Anaesthesiology, 22, 6, 718-24. 
Williams, M. (2007). Comprehensive hospital medicine: An evidence based approach. 
Philadelphia: Saunders    Elsevier. 
Wukich, D. K. (January 01, 2015). Diabetes and its Negative Impact on Outcomes in 
Orthopaedic Surgery. World Journal of Orthopedics, 6, 3, 331-9. 
Zambouri, A. (January 01, 2007). Preoperative Evaluation and Preparation for Anesthesia and 
Surgery. Hippokratia, 11, 1, 13-21. 
 
 
 
